Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Patrick

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pharmacology|July 1, 1988
Pharmacokinetics and bioavailability of dilevalol in normotensive volunteersW G Kramer, N Nagabhushan, M B Affrime, et al.
Journal of Clinical Pharmacology|November 1, 1986
Multiple-dose albuterol kineticsM L Powell, M Chung, M Weisberger, et al.
Journal of Pharmaceutical Sciences|February 1, 1985
Comparative bioavailability and pharmacokinetics of three formulations of albuterolM L Powell, M Weisberger, R Gural, et al.
The American Journal of Cardiology|June 5, 1989
Antihypertensive effect of dilevalol is directly related to dose and plasma concentrationsB D Given, G Perentesis, J D Christopher, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 14, 2005
Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 351125, a CCR5 antagonistA Ghosal, S K Chowdhury, S Gupta, et al.
Clinical Pharmacology and Therapeutics|December 1, 1989
Pharmacokinetics and pharmacodynamics of dilevalolD M Tenero, M B Bottorff, B D Given, et al.
Journal of Clinical Pharmacology|February 1, 1995
Effect of food on the oral bioavailability of isosorbide-5-mononitrate administered as an extended-release tabletT Kosoglou, D J Kazierad, J J Schentag, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vitro uptake of SCH 27899 (evernimicin) by rat alveolar macrophagesS Zbaida, J Brieland, P Krieter, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1991
Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepamJ G Wagner, D A Ganes, K K Midha, et al.
Obstetrics and Gynecology|August 1, 1979
Evaluation of fetal monitoring by telemetryM R Neuman, J F Roux, J E Patrick, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pharmacology|July 1, 1988
Pharmacokinetics and bioavailability of dilevalol in normotensive volunteersW G Kramer, N Nagabhushan, M B Affrime, et al.
Journal of Clinical Pharmacology|November 1, 1986
Multiple-dose albuterol kineticsM L Powell, M Chung, M Weisberger, et al.
Journal of Pharmaceutical Sciences|February 1, 1985
Comparative bioavailability and pharmacokinetics of three formulations of albuterolM L Powell, M Weisberger, R Gural, et al.
The American Journal of Cardiology|June 5, 1989
Antihypertensive effect of dilevalol is directly related to dose and plasma concentrationsB D Given, G Perentesis, J D Christopher, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 14, 2005
Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 351125, a CCR5 antagonistA Ghosal, S K Chowdhury, S Gupta, et al.
Clinical Pharmacology and Therapeutics|December 1, 1989
Pharmacokinetics and pharmacodynamics of dilevalolD M Tenero, M B Bottorff, B D Given, et al.
Journal of Clinical Pharmacology|February 1, 1995
Effect of food on the oral bioavailability of isosorbide-5-mononitrate administered as an extended-release tabletT Kosoglou, D J Kazierad, J J Schentag, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vitro uptake of SCH 27899 (evernimicin) by rat alveolar macrophagesS Zbaida, J Brieland, P Krieter, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1991
Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepamJ G Wagner, D A Ganes, K K Midha, et al.
Obstetrics and Gynecology|August 1, 1979
Evaluation of fetal monitoring by telemetryM R Neuman, J F Roux, J E Patrick, et al.
Pageof 8